Editor's Note: From the Cyclooxygenase-2 Inhibitor Celecoxib to a Novel Class of 3-Phosphoinositide-Dependent Protein Kinase-1 Inhibitors.
Sign Up to like & getrecommendations! Published in 2019 at "Cancer research"
DOI: 10.1158/0008-5472.can-19-0502
Abstract: The editors are publishing this note to alert the readers to a concern about [this article][1] ([1][2]). The editors were made aware of apparent splicing between Western blot lanes 3 and 4 in Fig. 7B.… read more here.
Keywords: novel class; cyclooxygenase inhibitor; editor note; inhibitor celecoxib ... See more keywords